Ken Griffin Cybin Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding CYBN
# of Institutions
7Shares Held
54.4KCall Options Held
0Put Options Held
0-
Emfo, LLC24.5KShares$184,7860.01% of portfolio
-
Unique Wealth Strategies, LLC Burr Ridge, IL12.7KShares$95,8090.0% of portfolio
-
Covington Capital Management10KShares$75,5000.0% of portfolio
-
Kistler Tiffany Companies, LLC Berwyn, PA3.6KShares$27,1800.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.5KShares$18,8750.0% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1.25B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...